Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
about
PPARs and the cardiovascular systemAnalysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genesFull-length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino Acid transport in human primary trophoblast cellsSignaling and cytotoxic functions of 4-hydroxyalkenals.Review: Epigenetic regulation of adipocyte differentiation and adipogenesisAssessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis.Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytesAdvanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.The Role of PPARγ in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes.Reduced plasma nonesterified fatty acid levels and the advent of an acute lung injury in mice after intravenous or enteral oleic acid administrationCYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway.Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-A(y) Diabetic Mice.Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectivesCDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathwayImpact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.Regulation of Translational Efficiency by Disparate 5' UTRs of PPARgamma Splice Variants.PPARG in Human Adipogenesis: Differential Contribution of Canonical Transcripts and Dominant Negative Isoforms.Peroxisome proliferator-activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions.Comparative study between the effect of the peroxisome proliferator activated receptor-alpha ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5'-AMP-activated protein kinase-alpha1 in high-fat fed rats.PPARγ is involved in the hyperglycemia-induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages.The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population.Unconventional microarray design reveals the response to obesity is largely tissue specific: analysis of common and divergent responses to diet-induced obesity in insulin-sensitive tissuesRelationship of , , and polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
P2860
Q24642728-FFE76FBD-5B7D-4525-8208-E226DB120B46Q33522774-38850346-042F-4B35-A366-DC29421F9766Q33582787-A1050122-E0C0-4EE2-A166-FE7D6389DF56Q33595109-0E90EACA-1F12-46BE-B818-AA564C69CBABQ33803438-AEC2A521-35E9-42C1-8999-EE70A6C90102Q34139329-52DEE242-231E-4534-AB30-14F28CD1DFE7Q34176762-3B657386-1351-49A1-9337-38BCC2374216Q34230420-7D077615-F864-4075-B8FB-0DD1AAF7AB7CQ34776235-435B2BA8-9AF0-44B9-8D47-75084C750F9DQ34776819-C3E94E09-B47B-4BA4-BCC6-C3628C1232FBQ35646408-B007598D-84F8-45A0-A344-ECC99A81D7BDQ35864281-2F56923B-9185-42CE-8D64-868796830349Q36045588-1914DC28-9D9A-4A1A-BFD3-B867D92B411FQ36182783-F44811EB-47C9-414C-A856-D154FE59B4AFQ36210664-4166972D-1EFF-4D87-B1AD-4074F04689D8Q36927688-4C48BA79-A475-483F-9DF6-D458560BCBA5Q37392758-9993E401-F858-4566-961B-A0FD8118CC3CQ37397885-3D4D7BB8-65B7-4223-B178-EC4E3C61E074Q37474090-3F4BB956-7A05-495F-A1B6-03F4707F837EQ37694556-E3E7FB00-A210-4517-AF81-CEA75A9D0E22Q39013200-1C64D971-8187-43D8-A68A-39526D2C9E49Q43265043-283025F2-CF6A-4D4D-BDB1-29B089CC8933Q43415853-F28E061E-4D23-4DC6-A375-6CD4B94EAE89Q47143752-1BBCF5DF-797F-46D8-B7B8-EEDD0069AB7BQ57241025-B06587DA-422E-4915-9613-876B01957794Q58795640-21A168C3-C54B-449A-912B-30494F4F6F08
P2860
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@ast
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@en
type
label
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@ast
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@en
prefLabel
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@ast
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@en
P2093
P2860
P356
P1433
P1476
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders.
@en
P2093
Do-Young Yoon
Kyoung Lee
Min-Chul Cho
Sang-Gi Paik
P2860
P304
P356
10.1155/2008/679137
P577
2008-01-01T00:00:00Z